Combined toxic exposures and human health: Biomarkers of exposure and effect

International Journal of Environmental Research and Public Health

Volumn 8, Issue 3, 2011, Pages 629-647

  Silins, Ilona ^a   Högberg, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Biomarkers; Chemical mixture; Combined exposure; Occupational exposure

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; POLYCYCLIC AROMATIC HYDROCARBON; TUMOR MARKER;

BIOLOGICAL MONITORING; BLOOD TOXICITY; CHEMICAL CARCINOGENESIS; CHEMICAL STRESS; DISEASE PREDISPOSITION; DNA ADDUCT; EPIGENETICS; GENETIC SUSCEPTIBILITY; GENOTOXICITY; HUMAN; LIVER TOXICITY; LUNG TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; POPULATION EXPOSURE; REVIEW; TARGET ORGAN;

EID: 79953274294     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8030629     Document Type: Review

References (93)

1. Guidelines for the Health Risk Assessment of Chemical Mixtures; U.S. Environmental Protection Agency: Washington, DC, USA, September 1986.
2. Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures; U.S. Environmental Protection Agency: Washington, DC, USA, August 2000.
3. US-EPA Framework for Cumulative Risk Assessment; U.S. Environmental Protection Agency: Washington, DC, USA, 2003.
4. IPCS. Assessment of Combined Exposures. Available online: http://www.who.int/ipcs/methods/harmonization/areas/aggregate/en/index.html (accessed on 22 February 2011).
5. Council Conclusions on Combination Effects of Chemicals; Commission of the European Union: Brussel, Belgium, 2009.
6. Manno, M.; Viau, C.; Cocker, J.; Colosio, C.; Lowry, L.; Mutti, A.; Nordberg, M.; Wang, S. Biomonitoring for occupational health risk assessment (BOHRA). Toxicol. Lett. 2010, 192, 3-16.
7. Sexton, K.; Hattis, D. Assessing cumulative health risks from exposure to environmental mixtures-three fundamental questions. Environ. Health Perspect. 2007, 115, 825-832.
8. Groten, J.P.; Feron, V.J.; Suhnel, J. Toxicology of simple and complex mixtures. Trends Pharmacol. Sci. 2001, 22, 316-322.
9. Guidance Manual for the Assessment of Joint Toxic Action of Chemical Mixtures; U.S. Department of Health and Human Services Public Health Service, Agency for Toxic Substances and Disease Registry, Division of Toxicology: Atlanta, GA, USA, May 2004.
10. Cassee, F.R.; Groten, J.P.; van Bladeren, P.J.; Feron, V.J. Toxicological evaluation and risk assessment of chemical mixtures. Crit. Rev. Toxicol. 1998, 28, 73-101.
11. Mumtaz, M.M.; Ruiz, P.; De Rosa, C.T. Toxicity assessment of unintentional exposure to multiple chemicals. Toxicol. Appl. Pharmacol. 2007, 223, 104-113.
12. Mumtaz, M.M.; Tully, D.B.; El-Masri, H.A.; De Rosa, C.T. Gene induction studies and toxicity of chemical mixtures. Environ. Health Perspect. 2002, 110, 947-956.
13. Viau, C. Biological monitoring of exposure to mixtures. Toxicol. Lett. 2002, 134, 9-16.
14. Spurgeon, D.J.; Jones, O.A.; Dorne, J.L.; Svendsen, C.; Swain, S.; Sturzenbaum, S.R. Systems toxicology approaches for understanding the joint effects of environmental chemical mixtures. Sci. Total Environ. 2010, 408, 3725-3734.
15. Kortenkamp, A.; Backhaus, T.; Faust, M. State of the Art Report on Mixture Toxicity; The School of Pharmacy, University of London: London, UK, 2009.
16. Jenkins, S.; Raghuraman, N.; Eltoum, I.; Carpenter, M.; Russo, J.; Lamartiniere, C.A. Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ. Health Perspect. 2009, 117, 910-915.
17. Watson, W.P.; Mutti, A. Role of biomarkers in monitoring exposures to chemicals: Present position, future prospects. Biomarkers 2004, 9, 211-242.
18. Scherer, G. Biomonitoring of inhaled complex mixtures-ambient air, diesel exhaust and cigarette smoke. Exp. Toxicol. Pathol. 2005, 57, 75-110.
19. Guha, N.; Steenland, N.K.; Merletti, F.; Altieri, A.; Cogliano, V.; Straif, K. Bladder cancer risk in painters: a meta-analysis. Occup. Environ. Med. 2010, 67, 568-573.
20. A Review of Human Carcinogens-Part F; International Agency for Research on Cancer (IARC): Lyon, France, 2009; Volume 100F.
21. Bergvall, C.; Westerholm, R. Identification and determination of highly carcinogenic dibenzopyrene isomers in air particulate samples from a street canyon, a rooftop, and a subway station in Stockholm. Environ. Sci. Technol. 2007, 41, 731-737.
22. Alexandrie, A.K.; Warholm, M.; Carstensen, U.; Axmon, A.; Hagmar, L.; Levin, J.O.; Ostman, C.; Rannug, A. CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis 2000, 21, 669-676.
23. Elovaara, E.; Heikkila, P.; Pyy, L.; Mutanen, P.; Riihimaki, V. Significance of dermal and respiratory uptake in creosote workers: exposure to polycyclic aromatic hydrocarbons and urinary excretion of 1-hydroxypyrene. Occup. Environ. Med. 1995, 52, 196-203.
24. McClean, M.D.; Rinehart, R.D.; Ngo, L.; Eisen, E.A.; Kelsey, K.T.; Wiencke, J.K.; Herrick, R.F. Urinary 1-hydroxypyrene and polycyclic aromatic hydrocarbon exposure among asphalt paving workers. Ann. Occup. Hyg. 2004, 48, 565-578.
25. Seidel, A.; Spickenheuer, A.; Straif, K.; Rihs, H.P.; Marczynski, B.; Scherenberg, M.; Dettbarn, G.; Angerer, J.; Wilhelm, M.; Bruning, T.; Jacob, J.; Pesch, B. New biomarkers of occupational exposure to polycyclic aromatic hydrocarbons. J. Toxicol. Environ. Health A 2008, 71, 734-745.
26. Caro, J.; Gallego, M. Environmental and biological monitoring of volatile organic compounds in the workplace. Chemosphere 2009, 77, 426-433.
27. Jarabek, A.M.; Pottenger, L.H.; Andrews, L.S.; Casciano, D.; Embry, M.R.; Kim, J.H.; Preston, R.J.; Reddy, M.V.; Schoeny, R.; Shuker, D.; Skare, J.; Swenberg, J.; Williams, G.M.; Zeiger, E. Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization. Crit. Rev. Toxicol. 2009, 39, 659-678.
28. Ryan, P.B.; Burke, T.A.; Cohen Hubal, E.A.; Cura, J.J.; McKone, T.E. Using biomarkers to inform cumulative risk assessment. Environ. Health Perspect. 2007, 115, 833-840.
29. Mahadevan, B.; Keshava, C.; Musafia-Jeknic, T.; Pecaj, A.; Weston, A.; Baird, W.M. Altered gene expression patterns in MCF-7 cells induced by the urban dust particulate complex mixture standard reference material 1649a. Cancer Res. 2005, 65, 1251-1258.
30. Henderson, R.F.; Bechtold, W.E.; Bond, J.A.; Sun, J.D. The use of biological markers in toxicology. Crit. Rev. Toxicol. 1989, 20, 65-82.
31. Angerer, J.; Ewers, U.; Wilhelm, M. Human biomonitoring: state of the art. Int. J. Hyg. Environ. Health 2007, 210, 201-228.
32. Esteban, M.; Castano, A. Non-invasive matrices in human biomonitoring: A review. Environ. Int. 2009, 35, 438-449.
33. Amorim, L.C.; de L. Cardeal, Z. Breath air analysis and its use as a biomarker in biological monitoring of occupational and environmental exposure to chemical agents. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 853, 1-9.
34. USEPA. Biomarkers for Cumulative Risk Assessment. Available online: http://www.epa.gov/hhrp/quick_finder/biomarkers.html (accessed on 11 December 2009).
35. Ceppi, M.; Biasotti, B.; Fenech, M.; Bonassi, S. Human population studies with the exfoliated buccal micronucleus assay: Statistical and epidemiological issues. Mutat. Res. 2010, 705, 11-19.
36. Wang, G.; Fowler, B.A. Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol. Appl. Pharmacol. 2008, 233, 92-99.
37. Nordberg, G.F. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China. Toxicol. Lett. 2010, 192, 45-49.
38. Yoshioka, N.; Nakashima, H.; Hosoda, K.; Eitaki, Y.; Shimada, N.; Omae, K. Urinary excretion of an oxidative stress marker, 8-hydroxyguanine (8-OH-Gua), among nickel-cadmium battery workers. J. Occup. Health 2008, 50, 229-235.
39. Anand, S.S.; Mumtaz, M.M.; Mehendale, H.M. Dose-dependent liver tissue repair after chloroform plus trichloroethylene binary mixture. Basic Clin. Pharmacol. Toxicol. 2005, 96, 436-444.
40. Nunes de Paiva, M.J.; Pereira Bastos de Siqueira, M.E. Increased serum bile acids as a possible biomarker of hepatotoxicity in Brazilian workers exposed to solvents in car repainting shops. Biomarkers 2005, 10, 456-463.
41. Kaukiainen, A.; Vehmas, T.; Rantala, K.; Nurminen, M.; Martikainen, R.; Taskinen, H. Results of common laboratory tests in solvent-exposed workers. Int. Arch. Occup. Environ. Health 2004, 77, 39-46.
42. Backe, E.; Lotz, G.; Tittelbach, U.; Plitzko, S.; Gierke, E.; Schneider, W.D. Immunological biomarkers in salt miners exposed to salt dust, diesel exhaust and nitrogen oxides. Int. Arch. Occup. Environ. Health 2004, 77, 319-327.
43. Ulvestad, B.; Randem, B.G.; Andersson, L.; Ellingsen, D.G.; Barregard, L. Clara cell protein as a biomarker for lung epithelial injury in asphalt workers. J. Occup. Environ. Med. 2007, 49, 1073-1078.
44. Avila Junior, S.; Possamai, F.P.; Budni, P.; Backes, P.; Parisotto, E.B.; Rizelio, V.M.; Torres, M.A.; Colepicolo, P.; Wilhelm Filho, D. Occupational airborne contamination in south Brazil: 1. Oxidative stress detected in the blood of coal miners. Ecotoxicology 2009, 18, 1150-1157.
45. Vineis, P.; Husgafvel-Pursiainen, K. Air pollution and cancer: biomarker studies in human populations. Carcinogenesis 2005, 26, 1846-1855.
46. Costa, L.G. Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environ. Health Perspect. 1996, 104, 55-67.
47. Yano, Y.; Kodawara, T.; Hongo, H.; Yano, I.; Kishi, Y.; Takahashi, J.; Inui, K. Population analysis of myelosuppression profiles using routine clinical data after the ICE (ifosfamide/carboplatin/etoposide) regimen for malignant gliomas. J. Pharm. Sci. 2009, 98, 4402-4412.
48. Taioli, E.; Sram, R.J.; Binkova, B.; Kalina, I.; Popov, T.A.; Garte, S.; Farmer, P.B. Biomarkers of exposure to carcinogenic PAHs and their relationship with environmental factors. Mutat. Res. 2007, 620, 16-21.
49. Swenberg, J.A.; Fryar-Tita, E.; Jeong, Y.C.; Boysen, G.; Starr, T.; Walker, V.E.; Albertini, R.J. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. Chem. Res. Toxicol. 2008, 21, 253-265.
50. Dunn, B.K.; Wagner, P.D.; Anderson, D.; Greenwald, P. Molecular markers for early detection. Semin. Oncol. 2010, 37, 224-242.
51. Lindberg, H.K.; Vaananen, V.; Jarventaus, H.; Suhonen, S.; Nygren, J.; Hameila, M.; Valtonen, J.; Heikkila, P.; Norppa, H. Genotoxic effects of fumes from asphalt modified with waste plastic and tall oil pitch. Mutat. Res. 2008, 653, 82-90.
52. Varella, S.D.; Rampazo, R.A.; Varanda, E.A. Urinary mutagenicity in chemical laboratory workers exposed to solvents. J. Occup. Health 2008, 50, 415-422.
53. Mielzynska, D.; Siwinska, E.; Kapka, L.; Szyfter, K.; Knudsen, L.E.; Merlo, D.F. The influence of environmental exposure to complex mixtures including PAHs and lead on genotoxic effects in children living in Upper Silesia, Poland. Mutagenesis 2006, 21, 295-304.
54. Perera, F.P.; Hemminki, K.; Gryzbowska, E.; Motykiewicz, G.; Michalska, J.; Santella, R.M.; Young, T.L.; Dickey, C.; Brandt-Rauf, P.; De Vivo, I.; et al. Molecular and genetic damage in humans from environmental pollution in Poland. Nature 1992, 360, 256-258.
55. Besaratinia, A.; Kim, S.I.; Hainaut, P.; Pfeifer, G.P. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 2009, 137, 1127-1137. e5.
56. Hussain, S.P.; Schwank, J.; Staib, F.; Wang, X.W.; Harris, C.C. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 2007, 26, 2166-2176.
57. Cavallo, D.; Ursini, C.L.; Rondinone, B.; Iavicoli, S. Evaluation of a suitable DNA damage biomarker for human biomonitoring of exposed workers. Environ. Mol. Mutagen. 2009, 50, 781-790.
58. Bonassi, S.; Znaor, A.; Ceppi, M.; Lando, C.; Chang, W.P.; Holland, N.; Kirsch-Volders, M.; Zeiger, E.; Ban, S.; Barale, R.; Bigatti, M.P.; Bolognesi, C.; Cebulska-Wasilewska, A.; Fabianova, E.; Fucic, A.; Hagmar, L.; Joksic, G.; Martelli, A.; Migliore, L.; Mirkova, E.; Scarfi, M.R.; Zijno, A.; Norppa, H.; Fenech, M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007, 28, 625-631.
59. Duan, H.; Leng, S.; Pan, Z.; Dai, Y.; Niu, Y.; Huang, C.; Bin, P.; Wang, Y.; Liu, Q.; Chen, W.; Zheng, Y. Biomarkers measured by cytokinesis-block micronucleus cytome assay for evaluating genetic damages induced by polycyclic aromatic hydrocarbons. Mutat. Res. 2009, 677, 93-99.
60. Hattis, D.; Chu, M.; Rahmioglu, N.; Goble, R.; Verma, P.; Hartman, K.; Kozlak, M. A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis. Crit. Rev. Toxicol. 2009, 39, 97-138.
61. Diamanti-Kandarakis, E.; Bourguignon, J.P.; Giudice, L.C.; Hauser, R.; Prins, G.S.; Soto, A.M.; Zoeller, R.T.; Gore, A.C. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 2009, 30, 293-342.
62. Soto, A.M.; Sonnenschein, C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat. Rev. Endocrinol. 2010, 6, 363-370.
63. Foley, D.L.; Craig, J.M.; Morley, R.; Olsson, C.A.; Dwyer, T.; Smith, K.; Saffery, R. Prospects for epigenetic epidemiology. Am. J. Epidemiol. 2009, 169, 389-400.
64. Swan, S.H.; Main, K.M.; Liu, F.; Stewart, S.L.; Kruse, R.L.; Calafat, A.M.; Mao, C.S.; Redmon, J.B.; Ternand, C.L.; Sullivan, S.; Teague, J.L. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 2005, 113, 1056-1061.
65. Hogberg, J.; Hanberg, A.; Berglund, M.; Skerfving, S.; Remberger, M.; Calafat, A.M.; Filipsson, A.F.; Jansson, B.; Johansson, N.; Appelgren, M.; Hakansson, H. Phthalate diesters and their metabolites in human breast milk, blood or serum, and urine as biomarkers of exposure in vulnerable populations. Environ. Health Perspect. 2008, 116, 334-339.
66. Kamrin, M.A. Phthalate risks, phthalate regulation, and public health: A review. J. Toxicol. Environ. Health B Crit. Rev. 2009, 12, 157-174.
67. Koch, H.M.; Calafat, A.M. Human body burdens of chemicals used in plastic manufacture. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364, 2063-2078.
68. Fernandez, M.F.; Aguilar-Garduno, C.; Molina-Molina, J.M.; Arrebola, J.P.; Olea, N. The total effective xenoestrogen burden, a biomarker of exposure to xenoestrogen mixtures, is predicted by the (anti)estrogenicity of its components. Reprod. Toxicol. 2008, 26, 8-12.
69. Lopez-Espinosa, M.J.; Silva, E.; Granada, A.; Molina-Molina, J.M.; Fernandez, M.F.; Aguilar-Garduno, C.; Olea-Serrano, F.; Kortenkamp, A.; Olea, N. Assessment of the total effective xenoestrogen burden in extracts of human placentas. Biomarkers 2009, 14, 271-277.
70. Fernandez, M.F.; Olmos, B.; Granada, A.; Lopez-Espinosa, M.J.; Molina-Molina, J.M.; Fernandez, J.M.; Cruz, M.; Olea-Serrano, F.; Olea, N. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: A nested case-control study. Environ. Health Perspect. 2007, 115, 8-14.
71. Wittke, K.; Hajimiragha, H.; Dunemann, L.; Begerow, J. Determination of dichloroanilines in human urine by GC-MS, GC-MS-MS, and GC-ECD as markers of low-level pesticide exposure. J. Chromatogr. B Biomed. Sci. Appl. 2001, 755, 215-228.
72. Lacasana, M.; Lopez-Flores, I.; Rodriguez-Barranco, M.; Aguilar-Garduno, C.; Blanco-Munoz, J.; Perez-Mendez, O.; Gamboa, R.; Bassol, S.; Cebrian, M.E. Association between organophosphate pesticides exposure and thyroid hormones in floriculture workers. Toxicol. Appl. Pharmacol. 2010, 243, 19-26.
73. Christiansen, S.; Scholze, M.; Axelstad, M.; Boberg, J.; Kortenkamp, A.; Hass, U. Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. Int. J. Androl. 2008, 31, 241-248.
74. Christiansen, S.; Scholze, M.; Dalgaard, M.; Vinggaard, A.M.; Axelstad, M.; Kortenkamp, A.; Hass, U. Synergistic disruption of external male sex organ development by a mixture of four antiandrogens. Environ. Health Perspect. 2009, 117, 1839-1846.
75. Main, K.M.; Skakkebaek, N.E.; Virtanen, H.E.; Toppari, J. Genital anomalies in boys and the environment. Best Pract. Res. Clin. Endocrinol. Metab. 2010, 24, 279-289.
76. Sharpe, R.M.; Skakkebaek, N.E. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil. Steril. 2008, 89, e33-e38.
77. Ho, S.M.; Tang, W.Y.; Belmonte de Frausto, J.; Prins, G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006, 66, 5624-5632.
78. Wild, C.P. Environmental exposure measurement in cancer epidemiology. Mutagenesis 2009, 24, 117-125.
79. Preston, R.J. Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints. Environ. Mol. Mutagen. 2005, 45, 214-221.
80. Laetz, C.A.; Baldwin, D.H.; Collier, T.K.; Hebert, V.; Stark, J.D.; Scholz, N.L. The synergistic toxicity of pesticide mixtures: implications for risk assessment and the conservation of endangered Pacific salmon. Environ. Health Perspect. 2009, 117, 348-353.
81. Committee on Toxicity Testing and Assessment of Environmental Agents. Toxicity Testing in the 21st Century: A Vision and a Strategy; National Research Council: Washington, DC, USA, 2007.
82. Martin, M.T.; Judson, R.S.; Reif, D.M.; Kavlock, R.J.; Dix, D.J. Profiling chemicals based on chronic toxicity results from the U.S. EPA ToxRef Database. Environ. Health Perspect. 2009, 117, 392-399.
83. Hainaut, P.; Wiman, K.G. 30 years and a long way into p53 research. Lancet Oncol. 2009, 10, 913-919.
84. Valdes, A.M.; Andrew, T.; Gardner, J.P.; Kimura, M.; Oelsner, E.; Cherkas, L.F.; Aviv, A.; Spector, T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366, 662-664.
85. Morla, M.; Busquets, X.; Pons, J.; Sauleda, J.; MacNee, W.; Agusti, A.G. Telomere shortening in smokers with and without COPD. Eur. Respir. J. 2006, 27, 525-528.
86. Broberg, K.; Bjork, J.; Paulsson, K.; Hoglund, M.; Albin, M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005, 26, 1263-1271.
87. Rafnar, T.; Sulem, P.; Stacey, S.N.; Geller, F.; Gudmundsson, J.; Sigurdsson, A.; Jakobsdottir, M.; Helgadottir, H.; Thorlacius, S.; Aben, K.K.; et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 2009, 41, 221-227.
88. Pavanello, S.; Pesatori, A.C.; Dioni, L.; Hoxha, M.; Bollati, V.; Siwinska, E.; Mielzynska, D.; Bolognesi, C.; Bertazzi, P.A.; Baccarelli, A. Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons. Carcinogenesis 2010, 31, 216-221.
89. Hoxha, M.; Dioni, L.; Bonzini, M.; Pesatori, A.C.; Fustinoni, S.; Cavallo, D.; Carugno, M.; Albetti, B.; Marinelli, B.; Schwartz, J.; Bertazzi, P.A.; Baccarelli, A. Association between leukocyte telomere shortening and exposure to traffic pollution: A cross-sectional study on traffic officers and indoor office workers. Environ. Health 2009, 8, 41.
90. Houben, J.M.; Moonen, H.J.; van Schooten, F.J.; Hageman, G.J. Telomere length assessment: Biomarker of chronic oxidative stress? Free Radic. Biol. Med. 2008, 44, 235-246.
91. Epel, E.S.; Lin, J.; Dhabhar, F.S.; Wolkowitz, O.M.; Puterman, E.; Karan, L.; Blackburn, E.H. Dynamics of telomerase activity in response to acute psychological stress. Brain. Behav. Immun. 2010, 24, 531-539.
92. Viau, C. Biomonitoring in occupational health: Scientific, socio-ethical, and regulatory issues. Toxicol. Appl. Pharmacol. 2005, 207, 347-353.
93. Bauer, S. Societal and ethical issues in human biomonitoring-A view from science studies. Environ. Health 2008, 7, S10.